March 2, 2010
Testing the amyloid hypothesis of Alzheimer’s disease in vivo
By Sam Gandy
In this issue of The Lancet Neurology, Rinne and colleagues1 report something of a...
March 2, 2010
Most researchers agree that the amyloid beta peptide, A-beta, is a key player in Alzheimer’s disease pathology. Exactly how it is involved is still unclear;...
February 25, 2010
•
Featured Donor
Alan Arnette is headed back to the mountains, this time planning to climb the highest peak on each continent while raising awareness and funds for Alzheimer...
February 22, 2010
From Cure Alzheimer's Fund President & CEO, Tim Armour:
Last week, I told you all that our federal government will spend $2 trillion on Alzheimer’s care in...
February 19, 2010
We first introduced you to Alan Arnette back in 2007 when he embarked upon an adventure he called “The Road Back to Mount Everest: Memories are Everything.” He...
February 17, 2010
•
From the President/CEO
From Cure Alzheimer's Fund President & CEO, Tim Armour:
I’ve been talking about the “cost of Alzheimer’s” for years, but we...
February 10, 2010
A Letter from Cure Alzheimer's Fund President & CEO, Tim Armour:
For 5 years now, we’ve been saying the same thing – with increased federal funding...
February 1, 2010
By Carolyn Mastrangelo
The saddest part is that my story isn’t unique. Many who read this will have similar ones to tell. Noticing that my mom wasn’t quite...
